Literature DB >> 8274736

Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias.

T Miki1, N Kawamata, A Arai, K Ohashi, Y Nakamura, A Kato, S Hirosawa, N Aoki.   

Abstract

Reciprocal exchanges between chromosomal region 3q27 and three loci of the Ig genes have been reported in cases of B-cell type non-Hodgkin's lymphoma. We have cloned a region containing a breakpoint junction of 3q27 from a cell line established from a patient with Burkitt's lymphoma carrying t(3;22)(q27;q11). The region cloned was shown to contain an Ig lambda light chain gene fused to a gene on chromosome 3q27. This finding was subsequently confirmed by fluorescence in situ hybridization. Extra nucleotides were present at the joining site. The heptamer-like and nonamer-like sequences separated by an intervening 24 bp were present in the region corresponding to the breakpoint of 3q27, suggesting that a misrecombination in Ig gene rearrangement may be involved in the translocation. Southern blot analysis with a 3q27-specific probe showed rearrangements in three additional patients with B-cell malignancies with the t(3;14)(q27;q32). The breakpoints of all four cases clustered within a limited 3-kb region on chromosome 3q27. The region of 3q27 involved in the translocation was designated as the BCL5 locus. The transcripts from the BCL5 locus were detected in normal tissues and hematopoietic cell lines, and the increased expression of transcript of aberrant size was detected in the established cell line carrying t(3;22). These observations suggest that a gene located at 3q27 is involved in the translocation and that its deregulation plays a role in the malignant transformation of B cells.

Entities:  

Mesh:

Year:  1994        PMID: 8274736

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas.

Authors:  Xing Wang; Zhiping Li; Akira Naganuma; B Hilda Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-29       Impact factor: 11.205

2.  Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.

Authors:  Tiemo Katzenberger; German Ott; Thomas Klein; Jörg Kalla; Hans Konrad Müller-Hermelink; M Michaela Ott
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

3.  BCoR, a novel corepressor involved in BCL-6 repression.

Authors:  K D Huynh; W Fischle; E Verdin; V J Bardwell
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

Review 4.  Molecular pathogenesis of diffuse large B-cell lymphoma.

Authors:  Christof Schneider; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Semin Diagn Pathol       Date:  2011-05       Impact factor: 3.464

5.  BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).

Authors:  M Butler; N Corbally; P A Dervan; D N Carney
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Disruption of the Bcl6 gene results in an impaired germinal center formation.

Authors:  T Fukuda; T Yoshida; S Okada; M Hatano; T Miki; K Ishibashi; S Okabe; H Koseki; S Hirosawa; M Taniguchi; N Miyasaka; T Tokuhisa
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

7.  Case of B-cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes.

Authors:  Keiki Kawakami; Setsuko Miyanishi; Takashi Sonoki; Shigeo Nakamura; Kenichi Nomura; Masafumi Taniwaki; Tetsuya Murata; Shigenori Kadowaki; Norimitsu Kadowaki; Ikuo Miura
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

8.  Characterization of Bcor expression in mouse development.

Authors:  Joseph A Wamstad; Vivian J Bardwell
Journal:  Gene Expr Patterns       Date:  2007-01-31       Impact factor: 1.224

9.  CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals.

Authors:  Mayumi Yoshimori; Ken-Ichi Imadome; Honami Komatsu; Ludan Wang; Yasunori Saitoh; Shoji Yamaoka; Tetsuya Fukuda; Morito Kurata; Takatoshi Koyama; Norio Shimizu; Shigeyoshi Fujiwara; Osamu Miura; Ayako Arai
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

10.  P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases.

Authors:  Mayumi Yoshimori; Honami Takada; Ken-Ichi Imadome; Morito Kurata; Kouhei Yamamoto; Takatoshi Koyama; Norio Shimizu; Shigeyoshi Fujiwara; Osamu Miura; Ayako Arai
Journal:  Cancer Med       Date:  2015-07-08       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.